4//SEC Filing
LANDBLOOM RONALD P 4
Accession 0001181431-08-050440
CIK 0001382911other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 8:21 PM ET
Size
9.3 KB
Accession
0001181431-08-050440
Insider Transaction Report
Form 4
LANDBLOOM RONALD P
VP, Medical and Regulatory
Transactions
- Exercise/Conversion
Common Stock
2008-08-25$2.00/sh+40,000$80,000→ 40,000 total - Sale
Common Stock
2008-08-25$11.28/sh−40,000$451,200→ 0 total - Exercise/Conversion
Common Stock (right to buy)
2008-08-25−40,000→ 200,000 totalExercise: $2.00Exp: 2016-09-28→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]The sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/18/2007.
- [F2]Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $11.00 to $11.92 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F3]As of August 25, 2008 and prior to this transaction, 109,791 shares of common stock subject to the option were vested. Approximately 5,208 shares of common stock subject to the option vest on the 15th day of each month until September 15, 2010.
- [F4]Not applicable.
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeother
Related Parties
1- filerCIK 0001396782
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 8:21 PM ET
- Size
- 9.3 KB